We are also following breaking news as firefighters battle a gas leak that erupted into a fire, a woman accused of putting tape on a child’s mouth at daycare and WRAL investigates a history of offenses at a Raliegh high school where a student was stabbed to death. Watch WRAL-TV at 7 p.m., and search for these and other stories on WRAL.com.

On WRAL at 7: Ice-cold wind and plunging temperatures 🥶 See how many hours we stay below freezing.  

A couple blames a faulty gun safe for the death of their 12-year-old son. Now they're trying to make sure the tragedy they're going through doesn't happen to anyone else.

Family claims gun safe was defective in seeking justice for 12-year-old son who shot himself

Carson Preston

If you are planning to ship holiday gifts this year, be sure to check this list of shipping deadlines from the United States Postal Service, UPS and FedEx so all your packages arrive on time.


Deadlines for 2023 holiday shipping with USPS, FedEx, UPS

Fedex Truck 

All assets associated with the tag: novavax

Novavax Coverage

Novavax and Morrisville-based FUJIFILM Diosynth-Biotechnologies have signed a settlement agreement by which FUJIFILM will receive $185 million.  Why?

Novavax to pay FUJIFILM Diosynth-Biotechnologies $185M under settlement following cancelled contract

Another biopharma expansion is underway in NC – $54M manufacturing plant

Starting Monday, Wake County COVID-19 vaccine clinics will feature the Novavax brand vaccine, which uses a protein-based technology to help prevent diseases like shingles, hepatitis B and the flu.

Wake, Durham County COVID vaccine clinics add Novavax vaccine

Updated COVID Shots Are Coming. Will They Be Too Late?

Dr. Rochelle Walensky, director of the US Centers for Disease Control and Prevention, said Tuesday that she has endorsed the recommendation of the agency's vaccine advisers to use the Novavax Covid-19 vaccine as a two-dose primary series in adults.

CDC signs off on Novavax Covid-19 vaccine for adults

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. And there's a North Carolina connection.

FDA approves a COVID-19 vaccine with a North Carolina connection

A federal advisory committee Tuesday voted to recommend that regulators authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.

FDA Advisers Back COVID Shots by Novavax, a Vaccine Latecomer

Novavax recently announced that it would delay its timeline for seeking U.S. authorization for its two-dose COVID-19 vaccine. This leaves thousands of Novavax trial participants stranded when it comes to travel, events and even jobs, because they can't get a different, approved vaccine.

Novavax COVID vaccine trial participants left battling a tough decision after FDA submission delayed

Novavax trial participants stuck as more restrictions placed on the unvaccinated 

Novavax is looking for more unvaccinated people to participate in trials testing the effectiveness of vaccines and boosters. But those trial participants are running into roadblocks in everyday life. 

BY-CASE BASIS. >>> THOUSANDS OF PARTICIPANTS IN THE NOVA FAX VACCINE TRIAL ARE FINDING THEMSELVES IN AN AWKWARD SITUATION WITH THE MANDATES COMING DOWN. >> THEY ARE AT RISK FOR NOT BEING ABLE TO TRAVEL, ATTEND CERTAIN EVENTS OR GO TO THE OFFICE, BECAUSE THEY ARE NOT ABLE TO GET ONE OF THE OTHER THREE APPROVED VACCINES. A RECENT DELIGHT IN THE TIMELINE SEEKING AUTHORIZATION LEAVES PARTICIPANTS FACING A BIG DECISION. WRAL LESLIE MORENO  SPOKE WITH THE LOCAL DOCTORS LEAVING A LOCAL TRIAL ABOUT THE OPTIONS PARTICIPANTS HAVE. >> Reporter: DR. MATTHEW HONG AT WAKE RESEARCH SAYS IT IS A TOUGH SITUATION TO BE IN AND HE UNDERSTANDS THE FRUSTRATION. HOWEVER, HE SAYS PATIENTS AND RESEARCHERS ARE BOTH REALLY JUST WAITING ON NOVAVAX'S NEXT MOVE  IN THE DIFFICULT PART IS THERE IS NO TELLING WHEN I COULD BE. THOUSANDS OF NOVAVAX PARTICIPANTS  ARE NOW PLAYING A WAITING GAME. >> DO I LEAVE THE TRIAL AND GO GET AN APPROVED VACCINE SO I'M NOT STRANDED IN THE MIDDLE? >> Reporter: HE HAS AC/DC VACCINE CARD THAT SAYS TRIAL PARTICIPANT, BUT HE IS STILL CONSIDERED UNVACCINATED WHEN HE TRIES TO LEAVE THE COUNTRY OR PARTICIPATE IN ACTIVITIES THAT REQUIRE AN FDA APPROVED VACCINE. >> CAN I TRAVEL TO EUROPE, FOR EXAMPLE. THAT EMA DOESN'T RECOGNIZE THE NOVAVAX VACCINE AT ALL. >> Reporter: EVERYONE  IN A NOVAVAX TRIAL IS ALREADY FULLY VACCINATED . THE PROBLEM IS IT'S NOT APPROVED BY THE FDA AND SOME PARTICIPANTS ARE ALREADY DROPPING OUT. >> A FEW MORE THAN WHAT WE'VE SEEN WITH THE OTHER TRIALS. BUT USUALLY THAT'S WHAT YOU FIND, IS PEOPLE ARE GOING OUT. >> Reporter: PARTICIPANTS CAN CHOOSE TO DROP OUT. HOWEVER, HE DOES NOT RECOMMEND MIXING VACCINES. >> IF THERE IS A CHANCE OF AN ENHANCED REACTION, IF YOU START MIXING VACCINES. >> Reporter: WHICH IS HIS BIGGEST CONCERN. >> THERE IS NO REAL HEALTH ORGANIZATION THAT RECOMMENDS MIXING AND MATCHING VACCINES, WHICH WOULD BE ESSENTIALLY WHAT ANY TRIAL PARTICIPANT WOULD HAVE TO DO IF THEY LEAVE AND GO GET AN APPROVED VACCINE. THAT'S THE PART WHERE I'M A LITTLE SCARED TO MESS WITH SCIENCE AT THE MOMENT. >> Reporter: DR. HONG SAYS THE EARLIEST WE CAN EXPECT TO HEAR SOME THINGS FROM NOVAVAX IS THIS OCTOBER. WE WILL JUST HAVE TO WAIT AND SEE. >> WHAT A DILEMMA.

Novavax, which developed a COVID-19 vaccine that is being manufactured by FUJIFILM Diosynth Biotechnologies, in a Morrisville facility, has announced the vaccine is about 90% effective overall.

Novavax study: COVID-19 vaccine about 90% effective

GSK partners with Sanofi for coronavirus vaccine effort

As the wait for federal approval to to start vaccinating children against COVID-19 continues, researchers at UNC Health are wasting no time with the Novavax vaccine.  



UNC recruiting kids for Novavax vaccine trial in big step toward herd immunity

UNC recruiting children for Novavax COVID-19 trial 

Novavax is looking for children between the ages of 12 and 17 for its COVID-19 vaccine trial at UNC. 

<p>&gt;&gt; IT TAKES A BIG STEP FORWARD IN NORTH CAROLINA WITH HOPES OF INCHING CLOSER TO THE MAGIC NUMBER NEEDED TO LIFT THE MASK MANDATE. GOOD EVENING. I AM GERALD OWENS. &gt;&gt; AND I AM DEBRA MORGAN. WE ARE JUST ABOUT AS CLOSE TO 50% AS YOU CAN GET. WE NEED 1.3 MILLION ADULTS TO GO GET THEIR FIRST DOSE TO GET US OVER THE LINE. AS WE WAIT FOR FEDERAL APPROVAL, RESEARCHERS ARE WASTING NO TIME WITH THE NOVAVAX VACCINE. LESLIE MORENO IS LIVE IN CHAPEL HILL. &gt;&gt; Reporter: NOVAVAX IS LOOKING FOR CHILDREN BETWEEN THE AGES OF 12 AND 17 FOR ITS VACCINE TRIAL HERE AT UNC. I SPOKE WITH DR. MICHELE HERNANDEZ WHO SAID ENROLLMENT DOES NOT OPEN UP TILL TOMORROW AND HAVE ALREADY RECEIVED EMAILS FROM PARENTS. STARTING TOMORROW FAMILIES WILL HAVE THE OPTION TO ENROLL THEIR CHILDREN IN THE NOVAVAX VACCINE TRIAL . SOME PARENTS ARE EAGER TO SIGN ABOUT OTHERS WANT TO WAIT A LITTLE LONGER. &gt;&gt; I GOT THE JOHNSON &amp; JOHNSON VACCINE THE WEEK THAT THEY BANNED IT. THAT THREW ME FOR A LOOP. &gt;&gt; Reporter: OFFERS AN EXPERIENCE HE WANTS TO DO SOME HOMEWORK BEFORE ENROLLING HIS SON IN A TRIAL . &gt;&gt; SIDE EFFECTS WOULD BE THE BIGGEST THING AND HOW LONG PEOPLE HAVE BEEN PARTICIPATING IN THE TRIAL. YOU HAVE TO BUILD A GROUND LEVEL OF DATA. &gt;&gt; Reporter: DR. MICHELE HERNANDEZ SAID THE NOVAVAX TRIAL IS A PLACEBO-CONTROLLED TRIAL WHERE TWO OR THREE PARTICIPANTS WILL RECEIVE THE VACCINE AND ONE IN THREE WILL RECEIVED THE PLACEBO. SHE SAID HEADACHES AND FATIGUE ARE COMMON AND IT IS PROTEIN BASED AND WILL HAVE TO BE STORED IN AN ULTRACOLD FREEZER. &gt;&gt; WE CAN DISTRIBUTE THIS GLOBALLY. IT DOESN'T REQUIRE AS MUCH HANDLING WITH FREEZING. &gt;&gt; Reporter: I ALSO REACHED OUT AND THE NOVAVAX TRIAL HAS BEEN ENROLLING CHILDREN ALL WEEK . SHE TELLS ME SHE BELIEVES THE TRIAL IS NECESSARY IF WE WANT SOME SENSE OF NORMALCY. &gt;&gt; I WOULDN'T HAVE A CHOICE, BUT I WOULD. OF MINE WERE AGED 12 TO 17 AND I READ THE GUIDELINES AND WAS ABLE TO BE INVOLVED, I THINK I WOULD. &gt;&gt; Reporter: THEY ARE HOPING TO SEE AT LEAST 100 PARTICIPANTS .</p>

UNC Infectious Disease Expert Dr. Cynthia Gay says the more vaccines we can get, the better. 